Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Source:http://linkedlifedata.com/resource/pubmed/id/17878314

Proc. Natl. Acad. Sci. U.S.A. 2007 Sep 25 104 39 15490-5

Download in:

View as

Triples

General Info

PMID
17878314